Horizon Therapeutics
HZNP
$116.30
Share price
0.00%
Change (1 day)
5.68%
Change (1 year)
Categories
Horizon Therapeutics (HZNP) - P/B ratio
P/B ratio as of April 2024 : 5.01
According to Horizon Therapeutics
's latest financial reports the company has a price-to-book ratio of 5.01.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Horizon Therapeutics - P/B ratio (from 2011 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 5.09 | -2.66% |
| 2021-12-31 | 5.23 | 30.43% |
| 2020-12-31 | 4.01 | 28.79% |
| 2019-12-31 | 3.11 | -0.5% |
| 2018-12-31 | 3.13 | 29.65% |
| 2017-12-31 | 2.41 | 16.94% |
| 2016-12-31 | 2.06 | -21.65% |
| 2015-12-31 | 2.64 | -10.97% |
| 2014-12-31 | 2.96 | -128.84% |
| 2013-12-31 | -10.3 | -856.2% |
| 2012-12-31 | 1.36 | -20.24% |
| 2011-12-31 | 1.70 | |
| 2010-12-31 | N/A | |
| 2009-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.64 | -67.23% | 🇺🇸 USA |
 Amgen AMGN | 22.8 | 355.32% | 🇺🇸 USA |
 Merck MRK | 8.49 | 69.37% | 🇺🇸 USA |
 AstraZeneca AZN | 5.44 | 8.50% | 🇬🇧 UK |
 Dr. Reddy's RDY | 3.76 | -24.97% | 🇮🇳 India |